- Home
- Publications
- Publication Search
- Publication Details
Title
KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma
Authors
Keywords
KRAS, NRAS, BRAF, GTPase, Kinase, Melanoma, Colorectal cancer, Squamous cell anal cancer, Mutation
Journal
MEDICAL ONCOLOGY
Volume 34, Issue 2, Pages -
Publisher
Springer Nature
Online
2017-01-10
DOI
10.1007/s12032-016-0879-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The potential role of Akt phosphorylation in human cancers
- (2017) J. Cicenas INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
- Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer
- (2016) M. Nicoś et al. Clinical & Translational Oncology
- The Aurora kinase inhibitors in cancer research and therapy
- (2016) Jonas Cicenas JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Multi-kinase inhibitors, AURKs and cancer
- (2016) Jonas Cicenas et al. MEDICAL ONCOLOGY
- The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer
- (2015) Sunny Guin et al. ACTA PHARMACOLOGICA SINICA
- Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma
- (2015) Dirk Schadendorf et al. EUROPEAN JOURNAL OF CANCER
- Sar1 GTPase Activity Is Regulated by Membrane Curvature
- (2015) Michael G. Hanna et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma
- (2015) Soo Young Kim et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
- (2015) Georgina V Long et al. LANCET
- Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial
- (2015) Jean Jacques Grob et al. LANCET ONCOLOGY
- Genetic analysis of the ‘uveal melanoma’ C918 cell line reveals atypicalBRAFand commonKRASmutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line
- (2015) Xiaoxing Yu et al. Pigment Cell & Melanoma Research
- BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
- (2015) Francesco Spagnolo et al. OncoTargets and Therapy
- Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies
- (2015) D. B. Johnson et al. Cancer Immunology Research
- Increased expression of ARF GTPases in prostate cancer tissue
- (2015) Claire Morgan et al. SpringerPlus
- Mitochondrial trafficking in neurons and the role of the Miro family of GTPase proteins
- (2015) Nicol Birsa et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Concordant analysis of KRAS, BRAF, PIK3CA mutations and PTEN expression between primary colorectal cancer and matched metastases
- (2015) Chen Mao et al. Scientific Reports
- The predictive value ofKRAS, NRAS, BRAF, PIK3CAand PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis
- (2014) Christina Therkildsen et al. ACTA ONCOLOGICA
- BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer
- (2014) Rona Yaeger et al. CANCER
- Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma
- (2014) Devalingam Mahalingam et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Role ofNRASmutations as prognostic and predictive markers in metastatic colorectal cancer
- (2014) Marta Schirripa et al. INTERNATIONAL JOURNAL OF CANCER
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
- (2014) Grant A McArthur et al. LANCET ONCOLOGY
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- COSMIC: exploring the world's knowledge of somatic mutations in human cancer
- (2014) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)
- (2014) Andrea Casadei Gardini et al. PLoS One
- Colorectal cancer: From prevention to personalized medicine
- (2014) Gemma Binefa WORLD JOURNAL OF GASTROENTEROLOGY
- Highlights of the Latest Advances in Research on CDK Inhibitors
- (2014) Jonas Cicenas et al. Cancers
- The Multifunctional Protein Kinase C-ε in Cancer Development and Progression
- (2014) Kirti Jain et al. Cancers
- Signaling networks of Rho GTPases in cell motility
- (2013) Samer Hanna et al. CELLULAR SIGNALLING
- A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis
- (2013) Cheryl Eifert et al. GENES CHROMOSOMES & CANCER
- Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation
- (2013) Filip Janku et al. Targeted Oncology
- Toward a Molecular Classification of Colorectal Cancer: The Role of Microsatellite Instability Status
- (2013) Karl Heinimann Frontiers in Oncology
- Toward a Molecular Classification of Colorectal Cancer: The Role of BRAF
- (2013) Alexandra Thiel et al. Frontiers in Oncology
- Melanoma: from mutations to medicine
- (2012) H. Tsao et al. GENES & DEVELOPMENT
- Global estimates of cancer prevalence for 27 sites in the adult population in 2008
- (2012) Freddie Bray et al. INTERNATIONAL JOURNAL OF CANCER
- The Ras protein superfamily: Evolutionary tree and role of conserved amino acids
- (2012) Ana Maria Rojas et al. JOURNAL OF CELL BIOLOGY
- Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic Melanoma
- (2012) Keith T. Flaherty et al. JOURNAL OF CLINICAL ONCOLOGY
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- RAS mutations and the development of secondary tumours in patients given BRAF inhibitors
- (2012) Sharan Prakash Sharma LANCET ONCOLOGY
- Vemurafenib: the first drug approved for BRAF-mutant cancer
- (2012) Gideon Bollag et al. NATURE REVIEWS DRUG DISCOVERY
- The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis
- (2012) Gholamreza Safaee Ardekani et al. PLoS One
- Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
- (2011) T Eisen et al. BRITISH JOURNAL OF CANCER
- NRAS mutation status is an independent prognostic factor in metastatic melanoma
- (2011) John A. Jakob et al. CANCER
- RAN GTPase as a Target for Cancer Therapy: Ran Binding Proteins
- (2011) K. J. Doherty et al. CURRENT MOLECULAR MEDICINE
- The CDK inhibitors in cancer research and therapy
- (2011) Jonas Cicenas et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Correlation of NRAS Mutations With Clinical Response to High-dose IL-2 in Patients With Advanced Melanoma
- (2011) Richard W. Joseph et al. JOURNAL OF IMMUNOTHERAPY
- Fine Tuning of Protein Kinase C (PKC) Isoforms in Cancer: Shortening the Distance from the Laboratory to the Bedside
- (2011) R. Bosco et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- The GDI-like solubilizing factor PDEδ sustains the spatial organization and signalling of Ras family proteins
- (2011) Anchal Chandra et al. NATURE CELL BIOLOGY
- Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
- (2011) Sergey I Nikolaev et al. NATURE GENETICS
- Role of Rab GTPases in Membrane Traffic and Cell Physiology
- (2011) Alex H. Hutagalung et al. PHYSIOLOGICAL REVIEWS
- Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma
- (2011) Bianca Devitt et al. Pigment Cell & Melanoma Research
- ProKinO: An Ontology for Integrative Analysis of Protein Kinases in Cancer
- (2011) Gurinder Gosal et al. PLoS One
- RAF protein-serine/threonine kinases: Structure and regulation
- (2010) Robert Roskoski BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Mouse Model of Melanoma Driven by Oncogenic KRAS
- (2010) C. Milagre et al. CANCER RESEARCH
- NRAS Mutations Are Rare in Colorectal Cancer
- (2010) Natsumi Irahara et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
- (2010) Wendy De Roock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ADP-Ribosylation Factors Modulate the Cell Surface Transport of G Protein-Coupled Receptors
- (2010) C. Dong et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases
- (2009) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma
- (2009) Axel Hauschild et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Rab GTPases as coordinators of vesicle traffic
- (2009) Harald Stenmark NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Role of Src in Solid Tumors
- (2009) D. L. Wheeler et al. ONCOLOGIST
- Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status
- (2009) Nadine Lukan et al. ONCOLOGY
- Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs
- (2008) Ilaria Cascone et al. EMBO JOURNAL
- Rho GTPases in cancer cell biology
- (2008) Francisco M. Vega et al. FEBS LETTERS
- The RanGTP gradient - a GPS for the mitotic spindle
- (2008) P. Kalab et al. JOURNAL OF CELL SCIENCE
- Role of Rho GTPases in breast cancer
- (2007) Yong Tang Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now